MeSH tree: D06.472.931
For many of us, the day doesn't start until we've had our first cup of coffee. It's comforting, energizing, and one of the most widely consumed beverages in the world. But while your morning brew might feel harmless, it can ...
Jun 2, 2025
0
29
Many female athletes and physically active women fail to consume enough energy to meet their bodies' needs, jeopardizing their reproductive and bone health and athletic performance, according to prior studies by researchers ...
May 27, 2025
0
10
Collegiate female endurance runners who experience chronic energy deficiency throughout a competitive season may compromise their performance and training benefits, according to a recent study by researchers in the Penn State ...
May 1, 2025
0
12
Red 3—also called FD&C Red No. 3, erythrosine or E127—has been widely used in food, cosmetics and pharmaceuticals since its FDA approval in 1969. You've likely encountered Red 3 before. It's a common additive to many candies, ...
Jan 23, 2025
0
15
Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone loss, according to a study being presented at the annual meeting of the Radiological Society of North ...
Nov 25, 2024
0
46
Patients undergoing peritoneal dialysis (PD) have significantly higher thyroxine (T4) concentrations than hemodialysis (HD) patients and higher free T4 (FT4) concentrations at 12 and 24 months, according to a study published ...
Sep 23, 2024
0
19
Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, sugary diet of the mother.
Sep 12, 2024
1
31
"I couldn't stop being sick. My side and my back were hurting and I just felt like my body was totally shutting down." That's how one woman described the side effects of weight loss injections she'd bought off-label in a ...
Aug 7, 2024
0
34
In an historic move, the Environmental Protection Agency on Tuesday banned the use of a pesticide that can harm fetuses.
Aug 7, 2024
0
23
Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone receptor beta (THRβ).
Aug 6, 2024
0
49
